MEDANTA Global Health Q4 FY26 results (Jan–Mar 2026) and concall
Global Health reported a strong Q4 FY26, with total income growing 25% year-on-year to INR 11,958 million and PAT increasing 40% to INR 1,417 million. The Noida facility continued its ramp-up, reducing its EBITDA loss, while mature hospitals maintained healthy performance despite a slight margin compression for the full year. The company also outlined significant expansion plans, including new greenfield projects and bed additions, supported by a strong net cash position.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 19.7%, net profit up 33.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 665 | 812 | 803 | 882 | 926 +39% | 940 +16% | 961 +20% |
| EBITDA | 150 | 202 | 195 | 195 | 193 +29% | 174 −14% | 193 −1% |
| Net profit | 104 | 131 | 93 | 152 | 140 +35% | 80 −39% | 124 +33% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
